OBJECTIVE: The aim of the present study was to evaluate the efficacy of a milkfat globule membrane (MFGM)-enriched protein fraction in a complementary food, on diarrhea, anemia, and micronutrient status. SUBJECTS AND METHODS: A randomized, double-blind controlled design to study 550 infants, 6 to 11 months old, who received daily for 6 months a complementary food (40 g/day) with the protein source being either theMFGM protein fraction or skim milk proteins (control). Health and nutritional status of infants were examined monthly in the outpatient clinic; product intake, food patterns, and diarrhea morbidity were assessed by home visits twice per week. Hemoglobin and micronutrient status were measured at 0 and 6 months of intervention. Results are presented as the entire group and as 6 to 8 and 9 to 11 months subgroups. RESULTS: A total of 499 infants completed the study. Global prevalence of diarrhea was 3.84% and 4.37% in the MFGM group and control group, respectively (P < 0.05). Consumption of the MFGM protein fraction reduced episodes of bloody diarrhea (odds ratio 0.54; 95% confidence interval 0.31-0.93, P = 0.025) adjusting for anemia and potable water facilities as covariates. There were no differences between groups in anemia, serum ferritin, zinc, or folate. CONCLUSIONS: Addition of an MFGM-enriched protein fraction to complementary food had beneficial effects on diarrhea in infants and may thus help to improve the health of vulnerable populations.
RCT Entities:
OBJECTIVE: The aim of the present study was to evaluate the efficacy of a milkfat globule membrane (MFGM)-enriched protein fraction in a complementary food, on diarrhea, anemia, and micronutrient status. SUBJECTS AND METHODS: A randomized, double-blind controlled design to study 550 infants, 6 to 11 months old, who received daily for 6 months a complementary food (40 g/day) with the protein source being either the MFGM protein fraction or skim milk proteins (control). Health and nutritional status of infants were examined monthly in the outpatient clinic; product intake, food patterns, and diarrhea morbidity were assessed by home visits twice per week. Hemoglobin and micronutrient status were measured at 0 and 6 months of intervention. Results are presented as the entire group and as 6 to 8 and 9 to 11 months subgroups. RESULTS: A total of 499 infants completed the study. Global prevalence of diarrhea was 3.84% and 4.37% in the MFGM group and control group, respectively (P < 0.05). Consumption of the MFGM protein fraction reduced episodes of bloody diarrhea (odds ratio 0.54; 95% confidence interval 0.31-0.93, P = 0.025) adjusting for anemia and potable water facilities as covariates. There were no differences between groups in anemia, serum ferritin, zinc, or folate. CONCLUSIONS: Addition of an MFGM-enriched protein fraction to complementary food had beneficial effects on diarrhea in infants and may thus help to improve the health of vulnerable populations.
Authors: Hamid Jan Jan Mohamed; Eric Kim Hor Lee; Kent Chee Keen Woo; Rajini Sarvananthan; Yeong Yeh Lee; Zabidi Azhar Mohd Hussin Journal: JGH Open Date: 2022-06-01
Authors: Xiaonan Li; Yongmei Peng; Zailing Li; Britt Christensen; Anne B Heckmann; Carina Lagerqvist; Hans Stenlund; Bo Lönnerdal; Olle Hernell; Christina E West Journal: PLoS One Date: 2021-05-13 Impact factor: 3.240
Authors: Claude Billeaud; Giuseppe Puccio; Elie Saliba; Bernard Guillois; Carole Vaysse; Sophie Pecquet; Philippe Steenhout Journal: Clin Med Insights Pediatr Date: 2014-11-03
Authors: Niklas Timby; Magnus Domellöf; Pernilla Lif Holgerson; Christina E West; Bo Lönnerdal; Olle Hernell; Ingegerd Johansson Journal: PLoS One Date: 2017-01-18 Impact factor: 3.240
Authors: M Carmen Crespo; Joao Tomé-Carneiro; Diego Gómez-Coronado; Emma Burgos-Ramos; Alba García-Serrano; Roberto Martín-Hernández; Shishir Baliyan; Javier Fontecha; César Venero; Alberto Dávalos; Francesco Visioli Journal: Sci Rep Date: 2018-03-05 Impact factor: 4.379